(Q33380269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Athanasios Fassas

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

601-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Brain damage when multiple sclerosis is diagnosed clinically

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Trends in survival and cause of death in Danish patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Interferons in relapsing remitting multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Rationale for bone marrow transplantation in the treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Stem cell transplantation for autoimmune disorders. Preclinical experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Stem cell transplantation for autoimmune disorders. Multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Collection of hematopoietic stem cells from patients with autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

G-CSF enhances the adhesion of encephalitogenic T cells to extracellular matrix components: a possible mechanism for exacerbation of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802197347

10.1080/08916930802197347

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18958762%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference